Literature DB >> 3589690

Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C.

W Plunkett, J O Liliemark, E Estey, M J Keating.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3589690

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  27 in total

Review 1.  Acute myelogenous leukaemia in children.

Authors:  S O Lie
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

2.  Modulation of cytosine arabinoside-induced proliferation inhibition by exogenous adenosylmethionine.

Authors:  E Rakasz; J Sugar; O Csuka
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 3.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

Review 4.  Progress in acute myeloid leukemia.

Authors:  Tapan M Kadia; Farhad Ravandi; Susan O'Brien; Jorge Cortes; Hagop M Kantarjian
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-09-19

Review 5.  Post-remission therapy for acute myeloid leukemia.

Authors:  Richard F Schlenk
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

6.  Acute Hepatotoxicity After High-Dose Cytarabine for the Treatment of Relapsed Acute Myeloid Leukemia: A Case Report.

Authors:  Samuel H Fu; Alexander H Flannery; Melissa L Thompson Bastin
Journal:  Hosp Pharm       Date:  2018-06-01

Review 7.  Clinical pharmacokinetics of cytarabine formulations.

Authors:  Akinobu Hamada; Takeo Kawaguchi; Masahiro Nakano
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.

Authors:  Caroline Palmeira dos Santos; Gustavo J S Pereira; Christiano M V Barbosa; Aron Jurkiewicz; Soraya S Smaili; Claudia Bincoletto
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

9.  Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology.

Authors:  V Gandhi; L E Robertson; M J Keating; W Plunkett
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.

Authors:  Aziz Nazha; Hagop Kantarjian; Farhad Ravandi; Xuelin Huang; Sangbum Choi; Guillermo Garcia-Manero; Elias Jabbour; Gautam Borthakur; Tapan Kadia; Marina Konopleva; Jorge Cortes; Alessandra Ferrajoli; Steve Kornblau; Naval Daver; Naveen Pemmaraju; Michael Andreeff; Zeev Estrov; Min Du; Mark Brandt; Stefan Faderl
Journal:  Am J Hematol       Date:  2013-09-09       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.